PPAR Research

SJR Rank #4,912H-index: 65SJR: 1.000Best quartile: Q1Open AccessAPC: US$1,630Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Drug DiscoveryQ1
  • Pharmacology (medical)Q1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Peroxisome Proliferator-Activated ReceptorsAdipose Tissue and MetabolismMetabolism, Diabetes, and CancerCancer, Lipids, and MetabolismEicosanoids and Hypertension PharmacologyInflammatory mediators and NSAID effectsLiver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic DiseasesCancer, Hypoxia, and MetabolismDrug Transport and Resistance Mechanisms

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs09182736

Documents per Year

202220250481216

Detailed Information

ISSN

1687-4757, 1687-4765

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.58

References per Document

45.75

Coverage

2006-2026

Scope

PPAR Research is a peer-reviewed, Open Access journal that publishes original research and review articles on advances in basic research focusing on mechanisms involved in the activation of peroxisome proliferator-activated receptors (PPARs), as well as their role in the regulation of cellular differentiation, development, energy homeostasis and metabolic function. The journal also welcomes preclinical and clinical trials of drugs that can modulate PPAR activity, with a view to treating chronic diseases and disorders such as dyslipidemia, diabetes, adipocyte differentiation, inflammation, cancer, lung diseases, neurodegenerative disorders, and obesity.

Metrics from SCImago Journal Rank 2025. View on SCImago